27/12/2017 17:30:23

Nuclear Networking Expands Marketing Services To Include Traditional Marketing

Greenwood Village, CO, Dec. 27, 2017 (GLOBE NEWSWIRE) -- Nuclear Networking announced today the expansion of its services options for their clients across the United States. New traditional marketing services include press releases content syndication, direct mail advertising. Other new digital services include app store optimization, intelligence list sourcing, social media advertising, YouTube advertising, Amazon optimization, and email marketing.

Nuclear Networking’s partnerships with expert marketers allow the company to expand client offerings and develop a more cohesive, full-stack marketing campaign for their partners.

“Today’s businesses looking to partner with firms for their marketing prefer firms that are integrated and provide all the services they are looking for in one place,” said Tyler Horsley, Director of Operations for Nuclear Networking. “In addition to keeping up with digital marketing trends, it’s important to remember that traditional advertising very much still has its place in a full stack marketing agency.”

With more than 190 clients, Nuclear Networking is now serving both large companies and SMBs who are interested in both digital and traditional marketing solutions while producing results that take half the time of other marketing firms. They are famous for showing positive results in as little as 45-90 days.

###

About Nuclear Networking

Nuclear Networking, a leading digital marketing agency located in the Denver Tech Center, Atlanta, Nebraska, and California. The Company, founded in 2010, provides clients unparalleled search engine optimization and pay-per-click services. Nuclear Networking helps boost marketing ROI up to 300% faster than competitors - delivering 4x- 5x the returns for over 84% of their clients. The company provides technical marketing services to B2B & B2C companies and marketing agencies, including white-label services. For more information visit www.nuclearnetworking.com or call (800) 984-6248.

Attachments:

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cfbd568e-a12d-4fa0-b94e-a094b2e21fbd

Attachments:

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3b1bf7e5-e111-4e56-9e95-ccb1ce4b37f7

Kelley Bjella

Nuclear Networking

800-984-6248

kelley@nuclearnetworking.com

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
20 Jun
 
I øjeblikket sidder "vinderne" ved folketingsvalget og forhandler regeringsgrundlag. De er enige om ..
44
18 Jun
 
Ingen grund til at flytte, de fleste har ikke råd, det er altid middelklassen det rammer og alligeve..
34
20 Jun
 
Måske jeg er den eneste, men savner Alpehue og hans gode indlæg... er han her under et andet alias? ..
23
23 Jun
 
Kære Nets-formand, du er i Danmark, ikke USA Vi er et samfund, hvor få har for meget og færre for li..
20
21 Jun
VELO
Mangel på to tacrolimus - konvertere pat. til Envarsus   I USA konvertere de patienter til Envarsus ..
20
21 Jun
 
@ckt - synes egentlig det havde vaeret bedre, du ikke havde skrevet noget overhovedet..
20
19 Jun
OMXC25
  De vil aldrig få penge nok. Jeg vil tro, at der aldrig er tilført de offentlige kasser flere penge..
20
20 Jun
CHEMM
ChemoMetec opjusterer forventningerne til omsætningen og driftsresultatet som følger af højere forve..
19
21 Jun
VELO
Ser ud til at man omkring 1 juli starter et nyt forsøg op med Envarsus hvor man tilsyneladende forve..
17
18 Jun
AMBU-B
Jeg er rigtig tilfred med de udmeldinger JJG kommer med idag. Det giver ro over deres udmeldinger, o..
17

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
OSE Immunotherapeutics Will Participate in HealthTech Investor Days (HTID)
2
Global Arena Holding Inc. (GAHC), Files First Quarter 10Q, and Updates Shareholders on Subsidiaries
3
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Eros International Plc (NYSE: EROS) and Encourages Eros Investors to Contact the Firm
4
Hofseth Biocare ASA: Signed Letter of Intent with Garden of Life® for exclusive use of CollaGo® and ProGo® in the US market
5
Final Data Analysis of Phase 2 PBC Trial Shows that Genkyotex’s Anti-fibrotic Candidate GKT831 Demonstrated Statistically Significant Improvements in GGT and ALP Over Full Treatment Period

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 June 2019 23:33:25
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB5 - 2019-06-25 00:33:25 - 2019-06-24 23:33:25 - 1000 - Website: OKAY